Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Interleukin-2 × 30 days × Clear all

Sponsor

Conditions

Melanoma 4 Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Recurrence 2 Neoplasm Metastasis 2 Lymphoma 2 Leukemia 2 Carcinoma, Non-Small-Cell Lung 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Stomach Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Meningeal Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Head and Neck Neoplasms 1

Interventions

Nivolumab 5 pembrolizumab 4 Specimen Handling 4 Biopsy 4 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 avelumab 2 Immunoglobulin G 2 Bevacizumab 2 talimogene laherparepvec 1 sargramostim 1 regorafenib 1 prednylidene 1 deltacortene 1 decitabine and cedazuridine drug combination 1 atezolizumab 1 aldesleukin 1 aflibercept 1 X-Rays 1 Sirolimus 1 Radiosurgery 1 Prednisone 1 Paclitaxel 1 NEO212 1 MAPRE1 protein, human 1 Lidocaine, Prilocaine Drug Combination 1 IFL protocol 1 Disulfides 1 Cyclophosphamide 1 Colony-Stimulating Factors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡